ResearcherFujita Health UniversityActive in the last 2 years
Yuichiro Uchida
Matched on ORCID iD 0000-0002-5347-4686; OpenAlex author ID A5031616979, A5125292023. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers
Papers 6
- Prognostic Impact of Major Pathologic Response After Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Retrospective S… Co-author DOI 10.1097/sla.0000000000007052↗
- Rapid Drug Sensitivity Profiling via a Novel High-Success-Rate Culture Method for Patient-Derived Pancreatic Cancer: An Exploratory Preclinical Platform for Ad… Co-author DOI 10.3390/cells15040313↗
- Association between patient's age and the utility of prognostic markers after pancreaticoduodenectomy for pancreatic cancer. Co-author DOI 10.1016/j.asjsur.2022.10.009↗
- Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial abutment; a prospective, open-label, phase… Co-author DOI 10.1186/s12885-022-09244-6↗
- Postoperative pancreatic fistulas decrease the survival of pancreatic cancer patients treated with surgery after neoadjuvant chemoradiotherapy: A retrospective… Co-author DOI 10.1016/j.suronc.2020.10.010↗
- A Prospective Study of Intensity-modified Radiation Therapy in Comparison with Conventional 3D-RT for BR Pancreatic Cancer Patients with Arterial Involvement. Co-author DOI 10.21873/anticanres.12172↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Toshihiko Masui · 5 shared papers, 2017–2026 · strength 0.68
- Paper Prognostic Impact of Major Pathologic Response After Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinom… DOI 10.1097/sla.0000000000007052↗
- Paper Association between patient's age and the utility of prognostic markers after pancreaticoduodenectomy for pancreatic ca… DOI 10.1016/j.asjsur.2022.10.009↗
- Paper Postoperative pancreatic fistulas decrease the survival of pancreatic cancer patients treated with surgery after neoadj… DOI 10.1016/j.suronc.2020.10.010↗
- Kazuyuki Nagai · 4 shared papers, 2020–2026 · strength 0.63
- Paper Prognostic Impact of Major Pathologic Response After Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinom… DOI 10.1097/sla.0000000000007052↗
- Paper Association between patient's age and the utility of prognostic markers after pancreaticoduodenectomy for pancreatic ca… DOI 10.1016/j.asjsur.2022.10.009↗
- Paper Postoperative pancreatic fistulas decrease the survival of pancreatic cancer patients treated with surgery after neoadj… DOI 10.1016/j.suronc.2020.10.010↗
- Asahi Sato · 4 shared papers, 2017–2026 · strength 0.57
- Paper Prognostic Impact of Major Pathologic Response After Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinom… DOI 10.1097/sla.0000000000007052↗
- Paper Association between patient's age and the utility of prognostic markers after pancreaticoduodenectomy for pancreatic ca… DOI 10.1016/j.asjsur.2022.10.009↗
- Paper Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial ab… DOI 10.1186/s12885-022-09244-6↗
- Etsuro Hatano · 3 shared papers, 2022–2026 · strength 0.51
- Paper Prognostic Impact of Major Pathologic Response After Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinom… DOI 10.1097/sla.0000000000007052↗
- Paper Association between patient's age and the utility of prognostic markers after pancreaticoduodenectomy for pancreatic ca… DOI 10.1016/j.asjsur.2022.10.009↗
- Paper Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial ab… DOI 10.1186/s12885-022-09244-6↗
- Shinji Üemoto · 3 shared papers, 2017–2022 · strength 0.28
- Paper Postoperative pancreatic fistulas decrease the survival of pancreatic cancer patients treated with surgery after neoadj… DOI 10.1016/j.suronc.2020.10.010↗
- Paper Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial ab… DOI 10.1186/s12885-022-09244-6↗
- Paper A Prospective Study of Intensity-modified Radiation Therapy in Comparison with Conventional 3D-RT for BR Pancreatic Can… DOI 10.21873/anticanres.12172↗
- Kyoichi Takaori · 3 shared papers, 2017–2022 · strength 0.28
- Paper Postoperative pancreatic fistulas decrease the survival of pancreatic cancer patients treated with surgery after neoadj… DOI 10.1016/j.suronc.2020.10.010↗
- Paper Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial ab… DOI 10.1186/s12885-022-09244-6↗
- Paper A Prospective Study of Intensity-modified Radiation Therapy in Comparison with Conventional 3D-RT for BR Pancreatic Can… DOI 10.21873/anticanres.12172↗
- Yu Kato · 1 shared paper, 2026 · strength 0.24
- Hideyuki Saya · 1 shared paper, 2026 · strength 0.24
- Michio Yoshimura · 2 shared papers, 2020–2022 · strength 0.23
- Paper Postoperative pancreatic fistulas decrease the survival of pancreatic cancer patients treated with surgery after neoadj… DOI 10.1016/j.suronc.2020.10.010↗
- Paper Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial ab… DOI 10.1186/s12885-022-09244-6↗
- Takashi Mizowaki · 2 shared papers, 2020–2022 · strength 0.23
- Paper Postoperative pancreatic fistulas decrease the survival of pancreatic cancer patients treated with surgery after neoadj… DOI 10.1016/j.suronc.2020.10.010↗
- Paper Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial ab… DOI 10.1186/s12885-022-09244-6↗
- Shintaro Yagi · 1 shared paper, 2026 · strength 0.21
- Masato Narita · 1 shared paper, 2026 · strength 0.21
- Kei Yamane · 1 shared paper, 2026 · strength 0.21
- Naoya Sasaki · 1 shared paper, 2026 · strength 0.21
- Yusuke Okamura · 1 shared paper, 2026 · strength 0.21
- Masashi Kanai · 2 shared papers, 2017–2022 · strength 0.17
- Paper Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial ab… DOI 10.1186/s12885-022-09244-6↗
- Paper A Prospective Study of Intensity-modified Radiation Therapy in Comparison with Conventional 3D-RT for BR Pancreatic Can… DOI 10.21873/anticanres.12172↗
- Akihisa Fukuda · 1 shared paper, 2022 · strength 0.11
- Keiko Shibuya · 1 shared paper, 2017 · strength 0.06
- Yökö Gotö · 1 shared paper, 2017 · strength 0.06
- Yuzo Kodama · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.